Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Greater transparency for oncology clinical trials reporting | Synapse
March 3, 2026
Greater transparency for oncology clinical trials reporting
DC
David Collingridge
Lancet Laboratories
AL
Allison Landman
RB
Robert G. Brierley
Ver todo
Puntos clave
Transparency in reporting may lead to enhanced methodological rigor in clinical trials.
Oncology clinical trials have often faced scrutiny for insufficient reporting transparency.
Improving reporting standards can help ensure better reproducibility and trust in oncology research.
Clear reporting could ultimately lead to better patient outcomes and informed treatment decisions.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Collingridge et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76673badf0bb9e87dd0be
https://doi.org/https://doi.org/10.1016/s1470-2045(26)00025-2